Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-0657-2020

Drug recall · January 22, 2020

Panther Platinum 30000 Capsules recall

Why: Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Panther Platinum 30000 Capsules, in green, black background with white, red text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX

Lots / codes

All lots remaining within expiry.

Quantity
1 box
Company
Motto International Corp, Dallas, TX
Distribution
TX
Initiated
December 17, 2019 · Voluntary: Firm initiated
Classified
January 10, 2020
Reported
January 22, 2020
Ended
October 29, 2021
How notified
Press Release

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.